background vitro vivo studies suggested genetic haplotypes impact mediated airway responses asthmatics strong linkage disequilibrium single nucleotide polymorphisms snps gene result limited number haplotypes intended evaluate impact haplotypes mediated airway responses development tolerance mild moderate asthmatics methods patients genotyped gene known bearing receptor function regulation cumulative dose response curves fenoterol versus pd20 methacholine fev1 constructed NUMBER week treatment periods terbutaline placebo double blind randomised design analysis dose response curves based repeated measurement analysis covariance results study population comprising NUMBER asthmatic patients limited allelic haplotypes resulting different genotypes data support existence differences genotypes shape dose response relationship agonist fenoterol propensity develop tolerance effects terbutaline substantiated endpoint pd20 methacholine conclusion genotypes differences exist baseline induced airway responses propensity develop tolerance maintenance therapy net differences weeks therapy magnitudes unlikely clinical significance beta2 agonist beta2 adrenoceptor beta2 adrenoceptor beta2 agonist beta2 adrenoceptor cross beta2 adrenoceptor pre treatment beta2 adrenoceptor beta2 agonist beta2 agonist